BNF - Chapter 8 - Immune system and malignant disease Flashcards

1
Q

Which immunosuppressant drugs have a role in the management of inflammatory bowel disease?

A
  • Azathiopurine
  • Ciclosporin
  • Mercaptopurine
  • Methotrexate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Other than chronic inflammatory diseases when else are immunosuppressants used?

A

They are used to suppress rejection in organ transplant recipients and to treat a variety of chronic inflammatory and autoimmune diseases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What may modification of tissue reactions caused by corticosteroids and other immunosuppressants result in?

A

The rapid spread of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What do antiproliferative drugs do?

A

Antiproliferative agents, also known as antimetabolites, inhibit cell-cycle pathways to limit T- and B-cell proliferation and thereby reducing the cytotoxic response directed toward the cardiac allograft.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Give a list of some antiproliferative immunosuppressants?

A
  • Azathioprine
    -Mercaptopurine
  • ## Mycophenolate mofetil
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is azathioprine metabolised to?

A

Mercaptopurine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When azathioprine is given with allopurinol should the dose stay the same?

A

Doses should be reduced when allopurinol is given concurrently

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which has a more selective mode of action - mycophenolate or azathioprine?

A

Mycophenolate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Are the corticosteroids immunosuppressants?

A

Yes they are powerful immunosuppressants

They are used to prevent organ transplant rejection, and in high dose to treat rejection episodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What inhibitor is ciclosporin?

A

Calcineurin inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Is ciclosporin an immunosuppressant?

A

Yes - it is a potent immunosuppressant which is virtually non-myelotoxic but markedly nephrotoxic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name another calcineurin inhibitor?

A

Tacrolimus;

Although not chemically related to ciclosporin it has a similar mode of action and side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Is the incidence of neurotoxicity greater with ciclosporin or tacrolimus?

A

It is greater with tacrolimus than with ciclosporin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name a non-calcineurin inhibiting immunosuppressant licensed for renal transplantation?

A

Sirolimus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is myelosuppression?

A

Suppression of the immune system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Azathioprine is an immunosuppressant metabolised to?

A

Mercaptopurine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are some hypersensitivity reactions of azathioprine?

A
  • malaise
  • dizziness
  • Vomiting
  • Diarrhoea
  • Fever
  • Myalgia
  • rash
  • hypotension
  • renal dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What should patients do if they experience any of these hypersensitivity reactions?

A

Withdraw treatment immediately

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What blood disorders can azathioprine cause?

A

Neutropenia and thrombocytopenia

Neutropenia is dose-dependent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What does the management of neutropenia and thrombocytopenia induced by azathioprine require?

A

Careful monitoring and dose adjustment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What symptom is common in the early stages of treatment with azathioprine?

A
  • Nausea is common and usually resolves in a few weeks without changing the dose.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

With azathioprine how can moderate nausea be managed?

A

By using divided daily doses, taking doses after food, prescribing antiemetics or temporarily reducing the dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What pre-screening treatment is important with azathioprine?

A

The enzyme thiopurine methyltransferase (TPMT) which metabolises thiopurine drugs (azathioprine, mercaptopurine, etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What risk is increased in patients with reduced activity of the enzyme TPMT?

A

Increases the risk of myelosuppression in patients with reduced activity of this enzyme (TPMT), thus TPMT activity should be measured before starting treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Which patients should not receive azathioprine based on their TPMT levels during pre screening?

A

Patient with absent TPMT activity should not receive this drug, those with reduced TPMT activity may be treated under specialist supervision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what monitoring requirements are there for azathioprine?

A

Monitor for toxicity throughout the treatment
Monitor full blood count weekly (more frequently with higher doses or if severe hepatic or renal impairment) for the first 4 weeks…. thereafter reduce the frequency of monitoring to every 3 months

• Blood tests and monitoring for myelosuppression are essential in long-term treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Is azathioprine prescribing brand specific?

A

Yes it is so it should be prescribed by brand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Ciclosporin is a potent immunosuppressant - does it also cause myelosuppression?

A

Not but it is nephrotoxic (toxic to the kidneys)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Does same brand need to be maintained for ciclosporin?

A

Yes - patients should be stabilised on a particular brand because switching between formulations without close monitoring can lead to important changes in blood-ciclosporin concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the common side effects when ciclosporin is used as an eye drop?

A

common side effects include eye discomfort and inflammation… as well as blurred vision.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are the monitoring requirements of ciclosporin?

A
  • blood ciclosporin concentration should be monitored throughout treatment
  • Renal function should be monitored - an increase in serum creatinine and urea may call for a dose reduction (in transplant patients) or discontinuation of treatment (in non-transplant patients)
  • Blood pressure should be monitored - discontinue if hypertension develops that cannot be controlled with antihypertensive
    Blood lipids should be measured before and after the first month of treatment
  • Monitor liver function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Before starting ciclosporin treatment for psoriasis and eczema how many times should blood pressure and renal function be measured?

A

Atleast twice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

In rheumatoid arthritis - for ciclosporin what other parameter would be monitored?

A
  • Serum creatinine at least twice before treatment.
    During treatment, monitor serum creatinine every 2 weeks for the first 3 months and then every month for a further 3 months.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Patients on ciclosporin should be advised to avoid what?

A

Avoid excessive exposure to UV light, including sunlight.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Is tacrolimus calcineurin inhibitor?

A

Yes which acts to suppress the immune system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Switching between oral tacrolimus products have been associated with what?

A

Associated with toxicity and transplant rejection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Do oral tacrolimus need to be prescribed by brand?

A

YEs to maintain therapeutic response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Give the different brands of tacrolimus and their daily frequency of administration?

A

daily (once in the morning and once in the evening)

  1. Modigraf granules make an immediate release oral suspension which is taken TWICE daily (once in the morning and once in the evening)
  2. Advagraf is a prolonged-release capsule that is taken ONCE daily in the morning.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What has been reported with tacrolimus blood concentrations much higher than the maximum levels in children?

A

Cardiomyopathy (disease of the heart muscle) has been reported to occur primarily in children with tacrolimus blood trough concentrations much higher than the recommended maximum levels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

For cardiomyopathy risk with tacrolimus what should patients be monitored for?

A

Patients should be monitored by echocardiography for hypertrophic changes – consider dose reduction or discontinuation if these occur.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Is mycophenolate mofetil a immunosuppressant?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

With mycophenolate what should be measured if there is recurrent infection?

A

Measure serum immunoglobulin and consider bronchiectasis (abnormal widening of the bronchi causing infection) or pulmonary fibrosis if persistent respiratory symptoms such as cough and dyspnoea (difficulty breathing) develop.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What other counselling should be given to patients taking mycophenolate mofetil?

A
  • patients should be warned to report immediately any signs or symptoms of bone marrow suppression e.g. infection or unexplained bruising or bleeding.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

What should be excluded before starting mycophenolate?

A
  • exclude pregnancy in females of child bearing age
  • 2 pregnancy tests 8-10 days apart are recommended
  • women should use at least 1 form of effective contraception before and during treatment, and for 6 weeks after discontinuation - 2 methods of effective contraception are preferred.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What is multiple sclerosis?

A

Multiple sclerosis is a chronic, immune-mediated, demyelinating inflammatory condition of the central nervous system, which affects the brain, optic nerves and spinal cord, and leads to progressive severe disability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What is the pattern of the disease?

A

Relapsing-remitting multiple sclerosis is the most common pattern of the disease. It is characterised by periods of exacerbation of symptoms (relapses) followed by unpredictable periods of stability (remission).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

On average how times a year does it occur?

A

The severity and frequency of relapses varies greatly between patients, but on average occur once or twice per year.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What does the clinical pattern of multiple sclerosis lead to?

A

This clinical pattern often develops into secondary-progressive multiple sclerosis, with progressive disability unrelated to relapses.

Most patients develop secondary progressive disease 6–10 years after onset.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

What is active disease (multiple sclerosis) defined as?

A

as at least two clinically significant relapses occurring within the last 2 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

What is highly active disease characterised as?

A

by an unchanged/increased relapse rate or by ongoing severe relapses compared with the previous year, despite treatment with interferon beta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

What is rapidly-evolving severe relapsing-remitting multiple sclerosis defined as?

A

By two or more disabling relapses in 1 year and one or more gadolinium-enhancing lesions on brain magnetic resonance imaging (MRI) or a significant increase in T2 lesion load compared with a previous MRI.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Is there a cure for multiple sclerosis?

A

No there is no cure for this

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Which drugs are used in the treatment of multiple sclerosis in England?

A
  • Interferon beta
  • Glatiramer Acetate
  • Fingolimod
  • Natalizumab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

What is believed to be a risk factor for developing multiple sclerosis?

A

Low levels of vitamin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

What are patients with diagnosed multiple sclerosis usually given?

A

Regular vitamin D after assessment of their serum levels of vitamin D, but there is insufficient evidence to support its use as a treatment for multiple sclerosis.

Patients should not be offered vitamin D solely for the purpose of treating multiple sclerosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

What is recommended for active relapsing-remitting multiple sclerosis?

A

. Interferon beta and glatiramer acetate

  • Peginterferon beta-1a requires less frequent administration and is available as an alternative to the non-pegylated interferon beta therapies.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Which drugs are preferred options for active disease?

A

Teriflunomide and dimethyl fumarate are treatment options for patients with active disease. They may be preferred due to their oral route of administration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

More active disease may be treated with what?

A

with natalizumab or alemtuzumab.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Which is the only one recommended for the treatment of rapidly-evolving severe relapsing-remitting multiple sclerosis?

A

natalizumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Which is the only drug licensed to be used in secondary progressive multiple sclerosis?

A
  • Interferon beta 1b
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Is there any drugs available for primary progressive multiple sclerosis?

A

Currently there are no effective disease-modifying treatments licensed for primary progressive multiple sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Are there any specific treatment for progressive-relapsing multiple sclerosis?

A

No specific treatment options for this type of multiple sclerosis. None of the currently licensed disease-modifying drugs are recommended in non-relapsing progressive disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Other than neurological dysfunction of multiple sclerosis - what are some of the other chronic symptoms?

A
  • chronic symptoms (such as fatigue, spasticity, visual problems, and emotional lability) produce much of the disability in multiple sclerosis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

What can increase the progression of disability in multiple sclerosis?

A

Smoking - therefore smoking cessation should be encouraged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

For suspected relapses what is recommended first line?

A

Oral methylprednisolone is recommended as the first-line option. Intravenous methylprednisolone should be considered as an alternative if oral methylprednisolone has failed or is not tolerated or if hospitalisation is required.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

Are vitamin B12 injections recommended as treatment for fatigue in patients with multiple sclerosis?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Which drug is licensed for the improvement of walking in patients with multiple sclerosis?

A
  • Fampridine

NICE do not consider it to be a cost-effective treatment and do not recommend its use.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

What factors may aggravate spasticity in multiple sclerosis?

A

constipation, infection, poor mobility aids, pressure ulcers, posture and pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

What are the first line options of managing spasticity in multiple sclerosis?

A
  • Baclofen
    or
  • Gabapentin (unlicensed)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

What are second and third line options for spasticity in multiple sclerosis?

A

Tizanidine or dantrolene sodium are second-line options; benzodiazepines may be used as third-line therapy and may also be effective in treating nocturnal spasms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

If other treatments are not effective then a 4 week trial of what can be offered?

A

A 4-week trial of cannabis extract can be offered as adjunctive treatment for moderate to severe spasticity in multiple sclerosis if other pharmacological treatments are not effective.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Is interferon beta a biological medicine?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

What should be noted about prescribing biological medicines?

A

Biological medicines must be dispensed by brand name

Manufacturer advises to record the brand name and batch number after each administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

What do cytotoxic drugs have?

A

They have both anti-cancer activity and the potential to damage normal tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Are most cytotoxic drug teratogenic?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

What are the pros and cons of combination of cytotoxic drugs?

A

Combinations of cytotoxic drugs, as continuous or pulsed cycles of treatment, are frequently more toxic than single drugs but have the advantage in certain tumours of enhanced response, reduced development of drug resistance and increased survival. However for some tumours, single-agent chemotherapy remains the treatment of choice.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

What are the key points of cytotoxic drug handling guidelines?

A

Trained personnel should reconstitute cytotoxics
Reconstitution should be carried out in designated pharmacy areas
Protective clothing (including gloves, gowns, and masks) should be worn
The eyes should be protected and means of first aid should be specified
Pregnant staff should avoid exposure to cytotoxic drugs (all females of child-bearing age should be informed of the reproductive hazard)
Use local procedures for dealing with spillages and safe disposal of waste material, including syringes, containers, and absorbent material
Staff exposure to cytotoxic drugs should be monitored

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

What is the dosing of cytotoxic drugs determined by?

A

using a variety of different methods including body-surface area or body-weight. Alternatively, doses may be fixed.

Doses may be further adjusted following consideration of a patient’s neutrophil count, renal and hepatic function, and history of previous adverse effects to the cytotoxic drug. Doses may also differ depending on whether a drug is used alone or in combination.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

what is oral mucositis - from chemotherapy?

A

A sore mouth is a common complication of cancer chemotherapy; it is most often associated with fluorouracil, methotrexate, and the anthracyclines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

What advice can you give for oral mucositis?

A

Good oral hygiene (rinsing the mouth frequently and effective brushing of the teeth with a soft brush 2–3 times daily) is probably beneficial. For fluorouracil, sucking ice chips during short infusions of the drug is also helpful.

Once a sore mouth has developed, treatment is much less effective.

In general, mucositis is self-limiting but with poor oral hygiene it can be a focus for blood-borne infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Which mouth wash should be used for oral mucositis?

A

Saline mouthwashes should be used but there is no good evidence to support the use of antiseptic or anti-inflammatory mouthwashes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Which patients are at risk of tumour lysis syndrome?

A

include those with non-Hodgkin’s lymphoma (especially if high grade and bulky disease), Burkitt’s lymphoma, acute lymphoblastic leukaemia and acute myeloid leukaemia (particularly if high white blood cell counts or bulky disease), and occasionally those with solid tumours.

Pre-existing hyperuricaemia, dehydration, and renal impairment are also predisposing factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

What are the features of tumour lysis syndrome?

A

Features include hyperkalaemia, hyperuricaemia (see below), and hyperphosphataemia with hypocalcaemia; renal damage and arrhythmias can follow. Early identification of patients at risk, and initiation of prophylaxis or therapy for tumour lysis syndrome, is essential.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Can chemotherapy worsen hyperuriceamia?

A

Yes - Hyperuricaemia, which may be present in high-grade lymphoma and leukaemia, can be markedly worsened by chemotherapy and is associated with acute renal failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

What should be started in hyperuricaemia in chemotherapy?

A
  • Allopurinol should be started 24 hours before treating such tumours and patients should be adequately hydrated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

The dose of which proliferative immunosuppressants should be reduced if allopurinol is used?

A

The dose of mercaptopurine or azathioprine should be reduced if allopurinol needs to be given concomitantly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Which other drug other than allopurinol can be used?

A
  • Febuxostat may also be used and should be started 2 days before cytotoxic therapy is initiated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

Which drug is licensed to be used for hyperuricaemia in patients with haematological malignancy?

A

Rasburicase, a recombinant urate oxidase, is licensed for hyperuricaemia in patients with haematological malignancy.

It rapidly reduces plasma-uric acid concentration and may be of particular value in preventing complications following treatment of leukaemias or bulky lymphomas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

Do all cytotoxic drugs cause bone-marrow supression?

A

Yes except vincristine sulfate and bleomycin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

Peripheral blood counts should be checked when?

A

Before each treatment and doses should be reduced or therapy delayed if bone-marrow has not recovered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

What should be noted about cytotoxic drugs and active infection?

A

Cytotoxic drugs may be contra-indicated in patients with acute infection; any infection should be treated before, or when starting, cytotoxic drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

What does fever in neutropenic chemotherapy patient (neutrophil count less than 1.06x10^9/Litre) require?

A

Requires immediate broad-spectrum antibacterial therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

What is symptomatic anaemia in chemotherapy patients usually treated with?

A

With red blood cell transfusions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

Is hair loss (alopecia) a complication of cytotoxic drugs?

A

Yes - it is a common complication, although it varies in degree between drugs and individual patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

Is there a pharmacological method to prevent alopecia (hair loss) from chemotherapy?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

Does chemotherapy increase the risk of thromboembolism?

A

Venous thromboembolism can be a complication of cancer itself, but chemotherapy increases the risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

Due to teratogenicity what should be excluded before starting cytotoxic drug?

A

Exclude pregnancy

Contraceptive advice should be given before cytotoxic therapy begins- women of childbearing age should use effective contraception during and after treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

Which cytotoxic drugs carry a greater risk for causing permanent male sterility?

A

Regimens that do not contain an alkylating drug or procarbazine may have less effect on fertility, but those with an alkylating drug or procarbazine carry the risk of causing permanent male sterility (there is no effect on potency).

Pretreatment counselling and consideration of sperm storage may be appropriate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

Are women also equally affected?

A

No women are less severely affected, although the span of reproductive life may be shortened by the onset of a premature menopause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

Is nausea and vomiting common with cytotoxic drugs?

A

Yes therefore prophylaxis of nausea and vomiting is extremely important

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

What is classed as acute symptom or delayed nausea and vomiting with chemotherapy?

A

Symptoms may be acute (occurring within 24 hours of treatment), delayed (first occurring more than 24 hours after treatment), or anticipatory (occurring prior to subsequent doses).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

Which are more difficult to treat?

A

Delayed and anticipatory symptoms are more difficult to control than acute symptoms and require different management.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

Which patients are more affected by nausea and vomiting with cytotoxic drugs?

A
  • women
  • patients under 50 years of age
  • anxious patients
  • those who experience motion sickness

Susceptibility also increases with repeated exposure to the cytotoxic drug.

104
Q

Drugs may be divided according to their emetogenic potential - give some examples?

A

Mildly emetogenic treatment—fluorouracil, etoposide, methotrexate (less than 100 mg/m2, low dose in children), the vinca alkaloids, and abdominal radiotherapy.

Moderately emetogenic treatment—the taxanes, doxorubicin hydrochloride, intermediate and low doses of cyclophosphamide, mitoxantrone, and high doses of methotrexate (0.1– 1.2 g/m2).

Highly emetogenic treatment—cisplatin, dacarbazine, and high doses of cyclophosphamide.

105
Q

For patients at low risk of emesis, pretreatment with which drugs may be used?

A

Dexamethasone or lorazepam

106
Q

For patients at high risk of emesis what is usually given?

A

A 5HT3-receptor antagonist (e.g. ondansetron) usually given by mouth in combination with dexamethasone and the neurokinin receptor antagonist aprepitant is effective

107
Q

What is used for the prevention of delayed emetic symptoms from chemotherapy?

A

For delayed symptoms associated with moderately emetogenic chemotherapy, a combination of dexamethasone and 5HT3-receptor antagonist is effective; for highly emetogenic chemotherapy, a combination of dexamethasone and aprepitant is effective. Rolapitant and metoclopramide hydrochloride are also licensed for delayed chemotherapy-induced nausea and vomiting.

108
Q

What about for prevention of anticipatory symptoms?

A

Lorazepam can be helpful for its amnesic, sedative and anxiolytic effects

109
Q

Anthracyclines are a class of drug used in chemotherapy - what induced side effects can these drugs cause?

A

Anthracycline-induced cardiotoxicity

The anthracycline cytotoxic drugs are associated with dose-related, cumulative, and potentially life-threatening cardiotoxic side-effects.

110
Q

What is given for the speed recovery from methotrexate-induced mucositis or myelosuppression?

A

Folinic acid (given as calcium folinate)

‘Folinic acid rescue’

111
Q

Folinic acid is also used for the treatment of methotrexate overdose, can it also be used for other folate antagonists such as trimethoprim?

A

No - Folinic acid does not counteract the antibacterial activity of folate antagonists such as trimethoprim

112
Q

When fluorouracil is used in colorectal cancer what other drug is it given with?

A

When folinic acid and fluorouracil are used together in metastatic colorectal cancer the response-rate improves compared to that with fluorouracil alone.

113
Q

Which other drug can be used for treatment of methotrexate overdose?

A

The calcium salt of levofolinic acid, a single isomer of folinic acid, is also used for rescue therapy following methotrexate administration, for cases of methotrexate overdose, and for use with fluorouracil for colorectal cancer. The dose of calcium levofolinate is generally half that of calcium folinate.

114
Q

Why should radiotherapy be avoided simultaneously with some cytotoxic antibiotics?

A

Many cytotoxic antibiotics act as radiomimetics and simultaneous use of radiotherapy should be avoided because it may markedly increased toxicity

115
Q

List examples of anthracycline antibiotics?

A

Daunorubicin, doxorubicin hydrochloride, epirubicin hydrochloride and idarubicin hydrochloride

116
Q

What is doxorubicin used for?

A

Conventional doxorubicin hydrochloride is used to treat the acute leukaemias, Hodgkin’s and non-Hodgkin’s lymphomas, paediatric malignancies, and some solid tumours including breast cancer.

117
Q

Whats the use of Epurubicin?

A

is structurally related to doxorubicin hydrochloride and can be used to treat breast cancer.

118
Q

What is the use of idarubicin?

A

Idarubicin hydrochloride has general properties similar to those of doxorubicin hydrochloride; it is mostly used in the treatment of haematological malignancies.

119
Q

What is the use of daunorubicin?

A

Daunorubicin also has general properties similar to those of doxorubicin hydrochloride.

120
Q

Give examples of vinca alkaloids?

A

vinblastine sulfate, vincristine sulfate, and vindesine sulfate,

121
Q

What are these vinca alkaloids used to treat?

A

are used to treat a variety of cancers including leukaemias, lymphomas, and some solid tumours

122
Q

Which cytotoxic drug class is the most widely used in cancer chemotherapy?

A

Alkylating drugs

123
Q

Give examples of alkylating drugs?

A
  • Cyclophosphamide
  • Ifosfamide
  • Melphalan
  • Lomustine
  • Carmustine
  • Estramustine
124
Q

When is Estramustine phosphate usually used?

A

Estramustine phosphate is a combination of an oestrogen and chlormethine used predominantly in prostate cancer. It is given by mouth and has both an antimitotic effect and (by reducing testosterone concentration) a hormonal effect.

125
Q

Which cytotoxic drug class does fluorouracil belong to?

A

Antineoplastic drugs (Antimetabolites)

126
Q

Is bleomycin a cytotoxic antibiotic?

A

Yes - and it is one of two cytotoxic drugs that does not cause myelosuppression

127
Q

Name the cytotoxic drugs that belong to the drug class - platinum compounds?

A
  • Carboplatin
  • Cisplatin
  • Oxaliplatin
128
Q

What route of administration is the only route that should be given for vinca alkaloids?

A

Intravenous route only

Intrathecal route can cause severe neurotoxicity, which is usually fatal

129
Q

What has the national safety agenecy advised of patients receiving their vinca alkaloid?

A

Adult and teenage patients should receive their vinca alkaloid dose in a 50ml minibag.

Teenagers and children treated in a child unit may receive their vinca alkaloid dose in a syringe

130
Q

What is the most common form of malignancy in women?

A

Breast cancer - especially in those over 50 years

131
Q

What are the risk factors of breast cancer?

A

age, early onset of menstruation, late menopause, older age at first completed pregnancy, and a family history of breast cancer.

The use of oral contraceptives or hormone replacement therapy (HRT) is also associated with an increased risk of breast cancer.

132
Q

Is breast cancer also common in men?

A

No it is rare in men

Although risk factors are not fully understood, it may be associated with abnormalities of sex hormone metabolism, including those caused by liver disease or testicular trauma, genetic predisposition, and environmental risk factors such as industrial exposure to chronic heat.

133
Q

What are additional risk factors of breast cancer?

A
  • Obesity and alcohol consumption
134
Q

Which two things can protect against breast cancer?

A
  • Physical activity and breast-feeding
135
Q

What is non-invasive breast cancer also known as?

A
  • Ductal carcinoma in situ

is when the cancer remains localised in the ducts

However, in most cases, the cancer is invasive at the time of diagnosis, which means that malignant cells are liable to spread beyond the immediate area of the tumour

136
Q

What can invasive breast cancer be defined as?

A

Invasive breast cancer, where malignant cells spread beyond the ducts, can be defined as early breast cancer (stage I/II), locally advanced disease (stage III) and advanced disease (stage IV).

137
Q

What is neoadjuvant drug therapy?

A

Drug treatment before surgery

138
Q

What is the purpose of neoadjuvant drug therapy for breast cancer?

A

aims to reduce the size of the tumour to allow breast-conserving surgery to be possible and to reduce axillary lymph node involvement.

139
Q

Is advanced breast cancer curable?

A

No and treatment aims to prolong survival, relieve symptoms and improve quality of life

140
Q

What are the three types of management involved in breast cancer?

A

Surgery
Radiotherapy
Drug therapy

or a combination of these

141
Q

In women with invasive breast cancer what is recommended?

A

Radiotherapy is recommended after breast conserving surgery with clear margins (no cancer cells are found at the edges of the removed tissues), as it reduces the local recurrence rates.

However, the use of radiotherapy may be omitted if risk of local recurrence is very low and the woman is willing to take adjuvant endocrine therapy for a minimum of 5 years.

142
Q

What may adjuvant drug therapy for breast cancer include?

A
  • chemotherapy
  • Endocrine therapy
  • Biological therapy
  • Bisphosphonate therapy
143
Q

In women with invasive breast cancer in only one breast who have not received treatment, including the use of neoadjuvant chemotherapy, NICE recommends the use of which tool to determine prognosis?

A

Recommends the use of the PREDICT tool to estimate prognosis and the absolute benefits of adjuvant therapy

144
Q

What adjuvant chemotherapy is recommended in patients with invasive breast cancer who are at sufficient risk of disease recurrence to require chemotherapy?

A

Adjuvant anthracycline-taxane combination

145
Q

Which biological therapy is used in breast cancer?

A

Trastuzumab

146
Q

Tamoxifen should be used in which women?

A

Should be used as an initial endocrine therapy in men and premenopausal women with oestrogen-receptor positive invasive breast cancer

147
Q

In addition suppression of what should be considered?

A

In addition, ovarian function suppression with a gonadotropin-releasing hormone (GnRH) should be considered in premenopausal women, taking into account the risk of temporary menopause. Ovarian function suppression aims to stop the production of circulating oestrogen, which can stimulate breast cancer progression.

It may be most beneficial in women who are at sufficient risk of disease recurrence to have been offered chemotherapy.

148
Q

What about in postmenopausal women with oestrogen receptor positive invasive breast cancer who are at medium or high risk of disease recurrence?

A

an aromatase inhibitor should be given as first-line therapy. Alternatively, tamoxifen should be given if an aromatase inhibitor is not tolerated or is contra-indicated, or if the risk of disease recurrence is low.

149
Q

how long is endocrine therapy as adjuvant therapy used for in breast cancer?

A

5 years

150
Q

Can endocrine therapy for ductal carcinoma in situ be used?

A

Following breast-conserving surgery, endocrine therapy should be offered to women with oestrogen-positive ductal carcinoma in situ, if radiotherapy is recommended but not given. If radiotherapy is not recommended, the use of endocrine therapy should also be considered.

151
Q

which bisphosphonate therapy can be used in breast cancer?

A

Zoledronic acid and sodium clodronate have been shown to improve disease-free survival and overall survival in postmenopausal women with node-positive invasive breast cancer. However, there is insufficient evidence to recommend their use in premenopausal women.

152
Q

Who should neoadjuvant chemotherapy be offered to?

A

should be offered to reduce tumour size in patients with oestrogen-receptor-negative invasive breast cancer.
In patients with oestrogen-receptor-positive invasive breast cancer, chemotherapy should be considered. In patients with HER2-positive invasive breast cancer, neoadjuvant chemotherapy should be offered in combination with trastuzumab and pertuzumab.

153
Q

What should be offered first line to post menopausal women with oestrogen-receptor positive advanced breast cancer?

A

Aromatase inhibitors should be offered to postmenopausal women with no previous history of endocrine treatment, or to those previously treated with tamoxifen.

154
Q

What should be offered first line for pre- and perimenopausal women with oestrogen-receptor-positive advanced breast cancer?

A

Tamoxifen in combination with ovarian function suppression should be offered as first-line treatment to pre- and perimenopausal women with oestrogen-receptor-positive advanced breast cancer not previously treated with tamoxifen.

155
Q

What should be offered first line to men with oestrogen-receptor-positive advanced breast cancer?

A

Tamoxifen

156
Q

Which monoclonal antibody is recommended for the treatment of HER2-positive advanced breast cancer?

A

Trastuzumab

It is used in combination with paclitaxel in those who have not received chemotherapy for metastatic breast cancer, and as monotherapy for patients who have received at least two chemotherapy regimens for metastatic breast cancer

157
Q

What should be offered to all women who have been identified as being at high-risk of developing breast cancer?

A

Chemoprevention

Should also be offered to women whoa are at moderate risk

158
Q

How many years should chemoprevention be continued for?

A

For 5 years

159
Q

Can anastrazole be given for chemoprevention of breast cancer to patients with severe osteoporosis?

A

No and instead tamoxifen can be given, provided there is no history or increased risk of thromboembolic disease or endometrial cancer

160
Q

What can some treatments used in the management of breast cancer such as tamoxifen or ovarian function suppression lead to?

A

may lead to menopausal symptoms or early menopause, and women should be counselled about these side-effects prior to starting any of these treatments.

161
Q

What should happen to a woman’s HRT if they are diagnosed with breast cancer?

A

It should be discontinued;
HRT should not be offered routinely to women with menopausal symptoms if they have a history of breast cancer;

however, in exceptional circumstances, HRT can be offered to women with severe menopausal symptoms once the associated risks have been discussed

162
Q

What drug class can be offered to treat menopausal symptoms such as hot flushes in women with breast cancer who are not taking tamoxifen?

A

SSRIs (Selective serotonin reuptake inhibitors)

.Clonidine hydrochloride, venlafaxine [unlicensed indication] and gabapentin [unlicensed indication] are sometimes used for the treatment of hot flushes in women with breast cancer after discussion with the patient and information given about side effects.

163
Q

What is the most common cancer affecting men?

A

Prostate cancer

164
Q

Can prostate cancer also affect transgender women?

A

Yes as the prostate is usually conserved after gender confirming surgery

165
Q

What are the main risk factors of prostate cancer?

A
  • most cases being diagnosed in men over 70 years of age
  • ethnicity (more common in black African-Caribbean men)
  • Obesity
  • Familial component
166
Q

Is prostate cancer a fast growing or slow growing disease?

A

usually Slow growing

167
Q

Is prostate cancer symptomatic or asymptomatic at diagnosis?

A

usually Asymptomatic

168
Q

What are the presenting symptoms of advanced disease of prostate cancer?

A
  • urinary outflow obstruction

- pelvic or back pain due to bone metastases

169
Q

What are the treatment options for prostate cancer?

A

Active surveillance, prostatectomy, radiotherapy (such as external beam), brachytherapy, hormone therapy, and chemotherapy. The benefits and risks of each option should be discussed with patients.

170
Q

What hormone therapy are included in managing prostate cancer?

A

Hormone therapy includes anti-androgen therapy—to block the effects of androgens, androgen deprivation therapy such as a luteinising hormone-releasing hormone (LHRH) agonist, or a gonadorelin antagonist—to reduce androgen levels, and bilateral orchidectomy—to remove the endogenous supply of androgens.

171
Q

For patients with low-risk localised prostate cancer what should be offered?

A

offer a choice between active surveillance, radical prostatectomy or radiotherapy.

Radical treatment should be offered to patients with localised prostate cancer undergoing active surveillance who show evidence of disease progression.

172
Q

What should be offered to patients with intermediate risk localised prostate cancer?

A

radical treatments (prostatectomy or radiotherapy) should be offered, and for those who decline them, active surveillance can be considered.

173
Q

What should be offered in those with high risk localised prostate cancer?

A

(when there is a realistic prospect of long-term disease control), and in those with locally advanced disease, radical prostatectomy or radiotherapy should be offered.

174
Q

In patients with intermediate‐risk and high-risk localised prostate cancer who have chosen radical radiotherapy, what should this be accompanied by?

A

In combination with androgen deprivation therapy

175
Q

How long should androgen deprivation therapy be given for?

A

Androgen deprivation therapy should be given for 6 months before, during or after radiotherapy; in patients with high‐risk localised prostate cancer, consider continuing therapy for up to 3 years.

176
Q

In patients with hormone-relapsed non-metastatic prostate cancer who are at high risk of developing metastatic disease what should be given?

A

darolutamide or apalutamide, with androgen deprivation therapy is recommended as a treatment option.

177
Q

What side effects may patients experience of prostate cancer treatment?

A

Patients should be informed about the side-effects of treatment; particularly urinary and sexual dysfunction, loss of fertility, radiation-induced enteropathy, osteoporosis, gynaecomastia, fatigue, and hot flushes.

178
Q

Patients who are on androgen deprivation therapy should be offered what?

A

A supervised exercise program (at least twice a week for 12 weeks) to reduce fatigue and improve quality of life.

179
Q

Should a bisphosphonate be offered to patients who have osteoporosis who are having androgen deprivation therapy?

A

Yes -A bisphosphonate should be offered to patients who have osteoporosis and who are having androgen deprivation therapy; denosumab is an alternative if bisphosphonates are not appropriate.

180
Q

What can occur with long term (longer than 6 months) bicalutamide treatment?

A

Gynaecomastia

181
Q

Is tamoxifen an anti-androgen?

A

Yes

182
Q

Effective contraception should be used during tamoxifen treatment and how many months after?

A

2 months after

183
Q

What drug class does anastrazole belong to?

A

Aromatase inhibitor

184
Q

What is the dose of anastrozole in chemotherapy of breast cancer?

A

1mg daily

185
Q

What is the dose of tamoxifen in chemotherapy of breast cancer?

A

20mg daily

186
Q

Does tamoxifen affect risk of throboembolism?

A

Yes - particulary during and immediately after major surgery r periods of immobility (consider interrupting treatment and initiating anticoagulant treatment)

187
Q

Other than anastrazole which other aromatase inhibitor is used for breast cancer?

A

Letrozole

188
Q

What is the dose of letrozole in chemotherapy in breast cancer treatment?

A

2.5mg daily

189
Q

Can thalidomide be used in pregnancy?

A

100% no - important teratogenic risk

190
Q

If rash occurs with thalidomide what should happen?

A

Stop treatment

191
Q

Does tamoxifen affect endometrial cancer risk?

A

Yes it increases endometrial cancer risk

Patients should report abnormal vaginal bleeding including menstrual irregularities, vaginal discharge and pelvic pain/pressure

192
Q

What is extravasation injury?

A
  1. A number of cytotoxic drugs will cause severe local tissue necrosis if leakage into the extravascular compartment occurs. To reduce the risk of extravasation injury, cytotoxic drugs should be administered by appropriately trained staff.
193
Q

Why does tumour lysis syndrome occur?

A
  1. Tumour lysis syndrome occurs due to rapid destruction of malignant cells (due to the drug or spontaneously). Features include hyperkalaemia, hyperuricaemia and hyperphosphataemia with hypocalcaemia. Renal damage and arthritis can follow.
194
Q

Which type of vaccines should patients on immunosuppressants avoid?

A

Avoid Live vaccines

195
Q

What is the MAO of azathioprine/mercaptopurine?

A

Azathioprine is metabolised to mercaptopurine

Mercaptopurine inhibits purine metabolism therefore DNA, RNA and protein synthesis.

196
Q

Why does dose of azathioprine/ mercaptopurine need to be reduced if given together with allopurinol?

A

Because allopurinol is a xanthine oxidase inhibitor; inhibits metabolism of purines

197
Q

Which is more selective, mycophenolate or azathioprine?

A

Mycophenolate is more selective

198
Q

What is a side effect of mycophenolate which is indicated by recurrent infections?

A

Hypogammaglobinaemia

Recurrent infections = measure serum immunoglobulin

199
Q

how long is contraception required for mycophenolate?

A

Women - two methods of effective contraception until 6 weeks after discontinuing

Men - use condom until 90 days after discontinuing OR female partners of male patients use effective contraception until 90 days

200
Q

What can tacrolimus affect in the blood?

A

Blood pressure
Hyperglycaemia
Hyperkalaemia
Hyperuricaemia

201
Q

What symptoms can indicate tacrolimus induced neurotoxicity?

A
  • Headaches and tremors
202
Q

What about diet should patients be advised who are taking tacrolimus?

A

Avoid high potassium and grapefruit juice = high tacrolimus level

203
Q

What does ciclosporin lower the activity of?

A

Lowers activity of T cells and their immune response

204
Q

Can ciclosporin cause gingival hyperplasia?

A

Yes

205
Q

What patient counselling should be given for ciclosporin?

A
  • Avoid excess sun exposure/ UV light: use wide spectrum SPF

- Diet : avoid high potassium and grapefruit juice = high ciclosporin level

206
Q

List the overall side effects of cytotoxic drugs?

A
  • Thromboembolism (increased risk)
  • Hyperuricaemia
  • Alopecia
  • Nausea and vomiting
  • Bone marrow suppression
  • urothelial toxicity
  • Oral mucositis
  • Pregnancy and reproductive function
207
Q

Which cytotoxic drugs cause permanent male sterility?

A

Alkylating drugs and procarbazine

Counsel patients on sperm storage

Women are less affected - early menopause may occur

208
Q

Describe what is tumour lysis syndrome?

A
  • caused by rapid destruction of malignant cells (high risk in lymphomas or leukaemias)
209
Q

What is the clinical features of tumour lysis syndrome?

A
  • hyperkalaemia
  • hyperuricaemia
  • Hyperphosphatemia
  • Hypocalcaemia

this is followed by renal failure and arrhythmias

210
Q

Which patients are at risk of tumour lysis syndrome?

A

Renal impairment
Dehydration
Hyperuricaemia

211
Q

Which cytotoxic drugs cause oral mucositis?

A
  • Anthracyclines

- Antimetabolites (methotrexate, Fluoruracil, Capecitabine)

212
Q

What is haemorrhagic cystitis?

A

Urothelilal toxicity =

Hemorrhagic cystitis - Which is an inflammation of the bladder defined by lower urinary tract symptoms that include dysuria, hematuria, and hemorrhage

213
Q

What is the drug used to treat urothelial toxicity?

A

Mesna

214
Q

Which cytotoxic drug is known to cause urothelial toxicity?

A

Cyclophosphamide (Alkylating drug)

215
Q

All cytotoxic drugs cause bone marrow suppression except which two?

A

vincristine

bleomycin

216
Q

If patient has fever with neutropenia and is on an immunosuppressant then what should be given?

A
  • broad spectrum antibiotic

Avoid paracetamol as it delays starting an antibiotic

217
Q

Which drug can be used to treat neutropenia associated with cancer medications?

A

Filgrastrim

218
Q

Hyperuricaemia is present in which types of cancers?

A

high grade lymphomas and leukaemia

markedly worsened by chemotherapy and associated with renal failure

219
Q

Which drugs can be used to treat hyperuricaemia in chemotherapy or cancer patients?

A

Allopurinol - 24 hours before treating such tumours, reduce dose of concomitant mercaptopurine/ azathioprine

Febuxostat - 2 days before if allopurinol contraindicated or not tolerated

Rasburicase - for hyperuricaemia associated with blood cancer (provides rapid decrease)

220
Q

Which cytotoxic drugs are mild emetogenics (cause nausea and vomiting)?

A

Methotrexate
Fluorouracil
Vinca Alkaloids

221
Q

Which cytotoxic drugs are moderate emetogenics?

A

Taxanes
Doxorubucin
Cyclophosphamide
High-dose MTX

222
Q

Which cytotoxic drugs are high emetogenics?

A

Cisplatin

High-dose cyclophosphamide

223
Q

Which drug can be used for anticipatory (before treatment) (thought of feeling sick) for chemotherapy?

A

Lorazepam

224
Q

What about acute symptoms (N+V) that are within 24 hours after chemotherapy?

A

Low risk of emesis= dexamethasone or lorazepam

High risk of emesis = Dexamethasone + 5-HT3 antagonist, aprepitant

225
Q

What is the treatment for delayed symptoms (N+V) more than 24 hours after chemotherapy?

A

Moderately emetogenic drugs = dexamethasone + 5HT3 antagonist

Highly emetogenic drugs = dexamethasone + Aprepitant

226
Q

Is alopecia associated with chemotherapy permanent?

A

No it is reversible hair loss - common complication of chemotherapy

227
Q

Is there a treatment available to prevent chemotherapy induced alopecia?

A

No

228
Q

What is extravasation of IV cytotoxic drugs?

A
  • Severe local tissue necrosis - if the drugs leak from the veins into the surrounding subcutaneous or subdermal tissue

(In worse cases it can lead to amputation)

229
Q

Which cytotoxic drugs are more prone to extravasation of IV drugs?

A

Vinca Alkaloids

Anthracyclines

230
Q

Do cytotoxic antibiotics radiomimetic?

A

Yes they are, therefore avoid concomitant radiotherapy = toxicity

231
Q

What are the two classes of cytotoxic antibiotics?

A
  • Anthracyclines

- Antineoplastic Antibiotics

232
Q

What is a good way to remember anthracyclines?

A

‘RUBICIN’

233
Q

List the anthracyclines?

A
  • Doxorubicin
  • Epirubicin
  • Idarubicin
  • Daunorubicin
234
Q

How is doxorubicin excreted?

A

Excreted in bile - reduce dose if high bilirubin

235
Q

What is a side effect of anthracyclines?

A
  • Cardiotoxicity (dose related: higher risk if given with herceptin)
236
Q

What colour does the urine be discoloured with anthracyclines e.g. Doxorubicin?

A

Red colour

237
Q

What do liposomal formulations of doxorubicin reduce incidence of?

A

Reduce incidence of cardiotoxicity and extravasation BUT cause:

  • Hand and Foot syndrome (Macular, red skin eruptions)
238
Q

Liposomal formulations of doxorubicin can cause hand and foot syndrome - what advice can you give?

A

Prevention:

Cool hands and feet and avoid socks and gloves for 4-7 days after treatment

239
Q

What is given as an antidote to anthracyclines?

A

Dexrazoxane -

is given for anthracycline-induced side effects, extravasation and overdose

240
Q

List an example of a antineoplastic antibiotic?

A
  • Bleomycin
241
Q

What are some important side effects of bleomycin?

A
  • Pulmonary Fibrosis = basal lung crapitations
  • Respiratory failure in anaesthesia
  • Hypersensitivity = chils and fever
    Prevention: IV hydrocortisone

Dermatological toxicity = hyperpigmentation, sclerotic plaques

242
Q

List the drugs that are vinca alkaloids?

A
  • Vincristine
  • Vinblastine
  • Vindesine
  • Vinflunine
  • Vinorelbine
243
Q

What route of administration is the only one allowed for vinca alkaloids?

A

Intravenous route only

244
Q

What is the risk of giving vinca alkaloids intrathecally?

A

Fatal neurotoxicity

245
Q

How should adults and teenagers unit receive their doses of vinca alkaloids in?

A
  • In a 50ml mini bag
246
Q

How should children’s unit receive doses in?

A

doses by syringes

247
Q

What is the general side effect of vinca alkaloids?

A

CNS toxicity (peripheral/autonomic neuropathy)

248
Q

Which cytotoxic drugs are known as antimetabolites?

A
  • Methotrexate (MTX)
  • Capecitabine (Pro-drug of 5-FU)
  • Florouracil (5-FU)
249
Q

What is the main side effects of cytotoxic antimetabolites?

A

Oral mucositis

Myelosuppression

250
Q

Which drug speeds up recovery in MTX side effects and overdose?

A

Folinic acid

251
Q

List cytotoxic drugs classed as the alkylating drugs?

A
  • Cyclophosphamide (causes urothelial toxicity)
  • Carmustine
  • Lomustine
  • Mephalan
  • Chlorambucil
  • Isosfamide
252
Q

What is the important side effects of alkylating drugs?

A
  • Permanent male sterility

- Non-lymphocytic leukaemia

253
Q

List the two aromatase inhibitors used in the treatment of breast cancer?

A
  • Anastrazole

- Letrozole

254
Q

Can aromatase inhibitors be used for pre-menopausal women?

A

No they cannot be used for pre-menopausal women as aromatase inhibitors are ‘anti-oestrogens’

255
Q

Give an example of a cytotoxic drug from the class Taxane?

A
  • Paclitaxel
256
Q

What are the main side effects of taxane cytotoxic drugs?

A
  • Cardiac disease
  • Pneuomonitis
  • Sepsis